A share price of Hims & Hers Health Inc [HIMS] is currently trading at $37.28, up 9.78%. An important factor to consider is whether the stock is rising or falling in short-term value. The HIMS shares have gain 20.76% over the last week, with a monthly amount glided 48.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on January 10, 2025, when Citigroup downgraded its rating to a Sell and also boosted its price target to $25 from $24. Previously, BTIG Research started tracking the stock with Buy rating on January 07, 2025, and set its price target to $35. On December 17, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $42 on the stock. BofA Securities downgraded its rating to a Underperform. Needham initiated its recommendation with a Buy and recommended $24 as its price target on August 22, 2024. Imperial Capital downgraded its rating to In-line for this stock on August 09, 2024. In a note dated May 22, 2024, Citigroup downgraded an Neutral rating on this stock and boosted its target price from $16 to $20.
Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $8.51 and $35.02. Currently, Wall Street analysts expect the stock to reach $24.67 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $37.28 at the most recent close of the market. An investor can expect a potential drop of -33.83% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 1.24B which represents 77.13% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.27 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.65 points at the first support level, and at 32.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.93, and for the 2nd resistance point, it is at 40.59.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 2.14. On the other hand, the Quick Ratio is 1.82, and the Cash Ratio is 1.08. Considering the valuation of this stock, the price to sales ratio is 6.56, the price to book ratio is 18.45 and price to earnings (TTM) ratio is 86.24.
Transactions by insiders
Recent insider trading involved Dudum Andrew, Officer, that happened on Jan 31 ’25 when 100000.0 shares were purchased. Chief Commercial Officer, Chi Michael completed a deal on Jan 24 ’25 to sell 17304.0 shares. Meanwhile, Chief Executive Officer Dudum Andrew sold 27098.0 shares on Jan 23 ’25.
